Mangoceuticals, Inc. MGRX
0.22 USD -0.01 (-4.39%)
At closeNov 3, 2026, 4:10 PM EST
0.21 -0.01 -3.17%
After hours · Nov 3, 4:10 PM ET
0.1964 Day range 0.2398
0.162 52-week range 2.41
- YTD
- -70.54%
- 1 year
- -88.28%
Financial health
Altman Z-Score
-6.14 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.3×
FY 2021 5y median -0.6× FY 2025
P/S 16.3×
FY 2021 5y median 8.1× FY 2025
P/B 0.5×
FY 2021 5y median 0.5× FY 2025
P/FCF -1.3×
FY 2021 5y median -1.3× FY 2025
EV/EBITDA -0.3×
FY 2021 5y median -0.7× FY 2025
EV/Sales 13.8×
FY 2021 5y median 8.0× FY 2025
FCF Yield -78.5%
FY 2021 5y median -78.5% FY 2025
Profitability
Gross Margin 54.9%
FY 2021 5y median 54.9% FY 2025
Operating Margin -4200.5%
FY 2021 5y median -1294.4% FY 2025
Net Margin -4526.9%
FY 2021 5y median -1413.6% FY 2025
ROE -135.8%
FY 2021 5y median -135.8% FY 2025
ROIC -123.5%
FY 2021 5y median -123.5% FY 2025
ROA -128.3%
FY 2021 5y median -128.3% FY 2025
Growth (YoY)
Revenue -26.0%
FY 2021 FY 2025
Operating Income -140.3%
FY 2021 FY 2025
EPS (diluted) 50.7%
FY 2021 FY 2025
Free Cash Flow -20.3%
FY 2021 FY 2025
Financial Health
Current Ratio 1.7×
FY 2021 5y median 1.7× FY 2025
Quick Ratio 1.7×
FY 2021 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2021 5y median 0.1× FY 2025
Interest Coverage -185×
FY 2021 5y median -185× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31